Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

External Validation of EPIC's Readmission Risk Model, the LACE+ Index and SQLape as Predictors of Unplanned Hospital Readmissions: A Monocentric, Retrospective, Diagnostic Cohort Study in Switzerland

NCT04306172 is registered in ClinicalTrials.gov with Luzerner Kantonsspital as lead sponsor.

NCT NCT04306172
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04306172 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
External Validation of EPIC's Readmission Risk Model, the LACE+ Index and SQLape as Predictors of Unplanned Hospital Readmissions: A Monocentric, Retrospective, Diagnostic Cohort Study in Switzerland
Lead sponsor
Luzerner Kantonsspital
Phase
Observational
Overall status
Completed
Start date
March 10, 2020
Completion date
October 1, 2020
Enrollment
23,116 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hospital readmission